Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study
- 518 Downloads
Mapping metabolic “signatures” can provide new insights into addictive mechanisms and potentially identify biomarkers and therapeutic targets.
We examined the differences in metabolites related to the tyrosine, tryptophan, purine, and oxidative stress pathways between cocaine-dependent subjects and healthy controls. Several of these metabolites serve as biological indices underlying the mechanisms of reinforcement, toxicity, and oxidative stress.
Metabolomic analysis was performed in 18 DSM-IV-diagnosed cocaine-dependent individuals with at least 2 weeks of abstinence and ten drug-free controls. Plasma concentrations of 37 known metabolites were analyzed and compared using a liquid chromatography electrochemical array platform. Multivariate analyses were used to study the relationship between severity of drug use [Addiction Severity Index (ASI) scores] and biological measures.
Cocaine subjects showed significantly higher levels of n-methylserotonin (p < 0.0017) and guanine (p < 0.0031) and lower concentrations of hypoxanthine (p < 0.0002), anthranilate (p < 0.0024), and xanthine (p < 0.012), compared to controls. Multivariate analyses showed that a combination of n-methylserotonin and xanthine contributed to 73% of the variance in predicting the ASI scores (p < 0.0001). Logistic regression showed that a model combining n-methylserotonin, xanthine, xanthosine, and guanine differentiated cocaine and control groups with no overlap.
Alterations in the methylation processes in the serotonin pathways and purine metabolism seem to be associated with chronic exposure to cocaine. Given the preliminary nature and cross-sectional design of the study, the findings need to be confirmed in larger samples of cocaine-dependent subjects, preferably in a longitudinal design.
KeywordsMetabolomics Methylation n methyl serotonin Cocaine Tryptophan Addiction Purine
This research was supported in part by grants DA00340 and DA015504 to AAP from the National Institute on Drug Abuse and also with funding from National Institutes of Health grants R24 GM078233, “The Metabolomics Research Network” (R.K.-D.), SMRI (R.K.-D.), NARSAD (R.K.-D.), and R01 NS054008-01A2, (R.K.-D.).
- Beck A, Steer R (1987) Manual for the Beck Depression Inventory. Psychological Corporation, San AntonioGoogle Scholar
- First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). American Psychiatric Press, WashingtonGoogle Scholar
- Hastie T, Tibshirani R, Friedman J (2001) The elements of statistical learning data mining inference and prediction. Springer, BerlinGoogle Scholar
- Kaddurah-Daouk R, Krishnan KR. Metabolomics (2009) A global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 34(1):173–186Google Scholar
- Karch SB (2006) Drug abuse handbook, 2nd edn. CRC, New York, pp 354–357Google Scholar
- Oleson EB, Talluri S, Childers SR, Smith JE, Roberts DC, Bonin KD et al (2009) Dopamine uptake changes associated with cocaine self-administration. Neuropsychopharmacology 34:1174–1184Google Scholar
- Venables WN, Ripley BD (2002) Modern applied statistics with S. Springer, BerlinGoogle Scholar
- Vianna EP, Ferreira AT, Naffah-Mazzacoratti MG, Sanabria ER, Funke M, Cavalheiro EA et al (2002) Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: fluorimetric, immunohistochemical, and Western blot studies. Epilepsia 43(Suppl 5):227–229PubMedCrossRefGoogle Scholar